Related Experiment Video
Updated: Aug 11, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada
Richard Sheppard1, Hassan Behlouli, Hugues Richard
1Sir Mortimer B. Davis/Jewish General Hospital, Montreal, Quebec, Canada.
Insights
Despite receiving less cardiac care, women with congestive heart failure (CHF) experienced similar health outcomes to men. This study found no significant gender gap in mortality for CHF patients.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Congestive heart failure (CHF) affects millions globally, with potential disparities in care based on gender.
- Understanding gender-based differences in treatment and outcomes is crucial for equitable healthcare delivery.
Purpose of the Study:
- To investigate potential gender disparities in the utilization of therapies and procedures for patients newly diagnosed with congestive heart failure (CHF).
- To compare clinical outcomes between men and women diagnosed with CHF at a population level.
Main Methods:
- A cohort of 16,017 men and 16,622 women diagnosed with CHF between 1998 and 2002 was identified using linked Quebec healthcare databases.
- Data included demographics, comorbidities, healthcare utilization (cardiologist visits, hospital stay), procedures (left ventricular function assessment, cardiac catheterization, revascularization), medication use (ACE inhibitors, beta-blockers), and mortality.
- Statistical analyses were performed to compare characteristics, treatment patterns, and outcomes between genders, adjusting for relevant factors.
Main Results:
- Women with CHF were older and had higher rates of hypertension and hyperlipidemia but lower rates of myocardial infarction compared to men.
- Women were less likely to see a cardiologist, undergo diagnostic cardiac catheterization or revascularization, and were prescribed ACE inhibitors less frequently.
- Despite these differences in care, women and men had similar rates of CHF rehospitalization and emergency room visits, with a minimally higher adjusted risk of death in men.
Conclusions:
- This population-level study indicates that women with newly diagnosed congestive heart failure receive less aggressive cardiac care, including fewer procedures and less frequent specialist consultations.
- However, clinical outcomes, including mortality and rehospitalization rates, were similar between men and women with CHF.
- Further research is warranted to explore the reasons for these observed treatment patterns and to ensure optimal, equitable care for all CHF patients.
Abstract:
This study assessed whether a gender gap exists in therapy, procedure use, and outcomes in patients who have a new diagnosis of congestive heart failure (CHF) at the population level. The Quebec hospital discharge database was linked with the physician and drug claims databases to identify a cohort of patients who had a diagnosis of CHF (code 428 in the International Classification of Diseases, Ninth Revision) between January 1998 and December 2002. There were 16,017 men and 16,622 women. Women who had CHF were older (78 +/- 11 vs 73 +/- 11 years, p <0.001), had more hypertension (41% vs 28%, p <0.001) and hyperlipidemia (18% vs 14%, p <0.001) but less frequent myocardial infarction (19% vs 25%, p <0.001). Women were less likely to see a cardiologist (30% vs 34%, p <0.001) and required a longer hospital stay (12.0 +/- 14.8 vs 10.6 +/- 13.3 days, p <0.001). During the first year after a first CHF hospitalization, women were less like to have an assessment of left ventricular function (61% vs 65%, p <0.001), diagnostic cardiac catheterization (11% vs 15%, p <0.001), and revascularization procedure (4% vs 6%, p <0.001). Women were less likely to be prescribed an angiotensin-converting enzyme inhibitor (60% vs 66%) and more likely to be prescribed a beta blocker (38% vs 34%). Women and men had similar yearly numbers of rehospitalizations for CHF (1.4 +/- 1.0 vs 1.5 +/- 1.0) and emergency room visits (1.7 +/- 1.2 vs 1.8 +/- 1.3). The adjusted risk of death was minimally higher in men than in women (hazard ratio 1.06, 95% confidence interval 1.03 to 1.1, p <0.01). Thus, despite less frequent cardiologist assessment, fewer cardiac-related procedures, and less frequent use of standard medical therapy, clinical outcomes in women and men who had CHF were similar.
More Related Videos
04:05Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure
Published on: June 30, 2023
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care